News AZ's Tagrisso gets NHS funding in Scotland SMC backs drug based on feedback from patients and doctors, after rejection by NICE.
News Ergomed hails insomnia and cancer deals UK biotech has stake in two potentially lucrative drugs thanks to hybrid business model
News Rare leukaemia drug gets funding for phase 2 trial Investment fund kick-starts phase 2 trial in CMML
News Innate and BMS' immunotherapy fails in phase 2 trial French biotech developing cancer immunotherapy with BMS.
News Opdivo still clear immunotherapy leader despite Keytruda gai... Immunotherapy takes on rivals from Roche and BMS.
Digital An AI supercomputer and discovering next-gen brain disorder ... Tarek Samad, Lundbeck’s senior vice president and head of research, discusses AI – specifically, Lundbeck’s agreement with the DCAI to operate Gefion.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
